CLINICAL_TRIALS
trial_result
· 2023-11-29
Clinical Trial Update: MRI Study of BAY 43-9006 in Metastatic Renal Cell Carcinoma [Phase 3]
Summary
Phase 3 MRI study update of BAY 43-9006 in metastatic renal cell carcinoma has been completed.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: University of Chicago | Conditions: Metastatic Renal Cell Carcinoma | Phase 3 | Status: COMPLETED